Presentation of Follicum at LSX Nordic Congress 30 August 2018

September 6, 2018

Presentation of Follicum at LSX Nordic Congress 30 August 2018

Follicum’s CEO Jan Alenfall presented the company at LSX Nordic Congress in Stockholm 30 August 2018.

See the presentation

For further information, please contact:
Jan Alenfall – CEO, Follicum AB
Telephone: +46 (0)46 – 19 21 97
Email: info@follicum.com

About Follicum AB
Follicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, Follicums research has resulted in a new peptide class which significantly increases the release of insulin in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Spotlight since 2014. www.follicum.com